Vimarsana
Biggest News Aggregation in the World

Novel Potent News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Novel Potent. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Novel Potent Today - Breaking & Trending Today

ORYZON to Present Positive Preclinical Efficacy Data of ORY-4001 in Charcot-Marie-Tooth (CMT) Disease at the 2023 Peripheral Nerve Society (PNS) Annual Meeting - Vimarsana News

ORYZON to Present Positive Preclinical Efficacy Data of ORY-4001 in Charcot-Marie-Tooth (CMT) Disease at the 2023 Peripheral Nerve Society (PNS) Annual Meeting

Published: May 30, 2023

30.05.2023 - Selected for Oral PresentationStudy done in the CMT1A mouse modelSupported by the CMT Research Foundation MADRID, Spain and BOSTON, May 30, 2023 (GLOBE NEWSWIRE) - Oryzon Genomics, S.A. (ISIN Code: ES0167733015, ORY), a clinical-stage ... Seite 1

Source: wallstreet-online.de
Related Topics:
United StatesJordi XausBella CenterPeripheral Nerve SocietyResearch FoundationNerve SocietyAnnual MeetingNovel PotentSelective Oxadiazole BasedShows Pre Clinical Therapeutic EfficacyOryzon Genomicss A
ST Pharm Presents Phase 1 Clinical Trial Results of HIV Treatment Candidate at AIDS 2022 - Vimarsana News

ST Pharm Presents Phase 1 Clinical Trial Results of HIV Treatment Candidate at AIDS 2022

Published: August 3, 2022

/PRNewswire/ -- ST Pharm Co., Ltd. (237690:KOSDAQ) announced on 3rd August that the Phase 1 clinical trial results of STP0404, the HIV treatment candidate, was...

Source: prnewswire.com
Related Topics:
Soult UkpyolsiSouth KoreaSource St Pharm Co LtdPrnewswire St Pharm Co LtdFirst In Human Clinical TrialNovel PotentAllosteric Integrase InhibitorSt Pharm Co